Skip to main content
. 2020 Mar 28;40(5):433–447. doi: 10.1007/s40261-020-00903-9

Fig. 1.

Fig. 1

Study design. FUP follow up period, i.v. intravenous, N number of participants, PK pharmacokinetic, fGPCR-AAb functionally active agonistic autoantibodies against G-protein-coupled receptors